Arkolith/Insider Trading/DYN/Form 4

Cox John

CEO & President, DirectorDyne Therapeutics, Inc. (DYN) · full profile →Form 4 · filed May 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$61K
Net Open-Market Flow
-$61K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2026Sell(S)3K$18.36$61K371K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-223955) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML